Myasthenia Gravis clinical trials at UC Irvine
1 in progress, 0 open to new patients

• Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis

  Sorry, in progress, not accepting new patients

  This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) as a corticosteroid (CS)-sparing agent in subjects with CS-dependent Myasthenia Gravis (MG).

  Orange, California and other locations

Last updated: July 12, 2018